Yash Innoventures Approves ₹5.34 Crore Proposed Rights Issue
Key highlights
- Yash Innoventures approved a proposed rights issue of up to ₹5.34 crore on 21 November 2026.
- Yash Innoventures plans to increase authorised share capital to ₹27 crore, subject to approvals.
- The company has scheduled an extraordinary general meeting for 17 December 2026.
- An earlier intimation referred to up to 55,00,000 equity shares with a face value of ₹10 each.
powered by IRIS

Yash Innoventures Ltd approved a proposed rights issue of up to ₹5.34 crore on 21 November 2026, alongside a plan to increase its authorised share capital to ₹27 crore. The proposals remain subject to shareholder and applicable regulatory approvals, with an extraordinary general meeting scheduled for 17 December 2026.
Know Yash Innoventures inside out
Results, valuation, peers and who's buying, in one view.
What did Yash Innoventures approve on 21 November 2026?
Yash Innoventures approved a proposed equity rights issue of up to ₹5.34 crore and an increase in its authorised share capital. A rights issue gives existing shareholders an opportunity to subscribe to new equity shares, generally in proportion to their existing holdings, subject to the final terms approved by the company and its shareholders.
The company’s filing identifies the rights issue as a proposed fund-raising measure. It does not disclose the issue price, record date, entitlement ratio, subscription period, use of proceeds, or the final number of shares to be issued. These terms are important because they determine the amount shareholders may be eligible to apply for and the eventual effect on the outstanding share capital.
The board action was taken on 21 November 2026. The filing makes clear that the proposed capital actions are not final until the required shareholder and regulatory approvals are received.
Why is Yash Innoventures increasing its authorised share capital?
Yash Innoventures plans to increase its authorised share capital to ₹27 crore. Authorised share capital is the maximum share capital that a company is permitted to issue under its constitutional documents. Increasing this limit can provide the legal capacity required for issuing additional equity shares.
The available background states that the company intended to raise authorised capital from ₹17 crore to ₹27 crore, implying an increase of ₹10 crore. The change requires a corresponding alteration to Clause V, the capital clause, of the Memorandum of Association, subject to shareholder approval.
An authorised-capital increase does not itself issue shares or raise cash. It creates the permitted headroom for the company to proceed with an equity issuance if shareholders approve the proposal and all other applicable requirements are met.
What are the disclosed details of the proposed rights issue?
Yash Innoventures has disclosed a proposed rights issue size of up to ₹5.34 crore, but the final commercial terms have not been provided in the filing. The company’s earlier board-meeting intimation referred to a proposal involving up to 55,00,000 equity shares with a face value of ₹10 each.
The filing information does not state whether the issue will be offered at face value, at a premium, or at another price. It also does not set out the record date, rights entitlement, renunciation facility, or timeline for opening and closing subscriptions. Investors therefore do not yet have sufficient disclosed information to calculate their likely entitlement or the issue’s precise dilution effect.
The stated ₹5.34 crore proposed issue size and the earlier reference to up to 55,00,000 shares are both drawn from the supplied disclosures. The company has not disclosed final issue terms that would explain or reconcile the final issue value with the earlier share proposal.
Got a follow-up? Ask IRIS
When will shareholders consider the Yash Innoventures proposals?
Shareholders will consider the proposals at an extraordinary general meeting scheduled for 17 December 2026. The EGM is the next disclosed corporate event connected with the proposed rights issue and the authorised-capital increase.
Shareholder approval is required for the authorised-capital change and the associated amendment to the Memorandum of Association. The filing also states that the rights issue is subject to shareholder and regulatory approvals. Until these processes are completed, the company has not announced a final rights issue timetable.
The company will need to make further disclosures if and when it fixes the issue structure. Such disclosures would ordinarily be relevant to shareholders because they would set out the terms on which eligible investors can participate.
How does the filing matter for Yash Innoventures shareholders?
The filing matters because it sets out a proposed equity fund-raising route and an expansion of the company’s permitted equity capital. Existing shareholders may be offered rights under the eventual issue terms, but the filing does not yet specify their entitlement or the cash amount they would need to invest to maintain their proportional holding.
For investors, the key unanswered matters are the issue price, the entitlement ratio, the record date, the total number of shares to be issued and the intended use of funds. Those factors will determine the financial structure of the proposal more clearly than the authorised-capital increase alone.
The company’s disclosure does not include a share-price reaction, financial forecast, or expected outcome from the fund raise. Accordingly, the filing supports only the conclusion that the board has approved a proposed capital-raising process that remains conditional.
Conclusion
Yash Innoventures has approved a proposed rights issue of up to ₹5.34 crore and a plan to raise authorised share capital to ₹27 crore. The actions indicate that the company is seeking shareholder authority and sufficient capital headroom for a potential equity issuance, but the final rights terms have not been disclosed.
The next disclosed milestone is the EGM on 17 December 2026. Investors will need to watch for the shareholder vote and subsequent company disclosures on the issue price, entitlement ratio, record date, subscription schedule and use of the proposed proceeds.


